
Louis Philipson
· Professor of Medicine Director, Kovler Diabetes CenterUniversity of Chicago · Global Health
Active 1956–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
Research topics
- Medicine
- Endocrinology
- Internal medicine
- Political Science
- Intensive care medicine
- Pathology
- Family medicine
- Biology
- Biochemistry
- Genetics
Selected publications
Diabetes Care · 2020 · 387 citations
The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision m…
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes
JAMA · 2020 · 344 citations
Importance: Continuous glucose monitoring (CGM) provides real-time assessment of glucose levels and may be beneficial in reducing hypoglycemia in older adults with type 1 diabetes. Objective: To determine whether CGM is effective in reducing hypoglycemia compared with standard blood glucose monitoring (BGM) in older adults with type 1 diabetes. Design, Setting, and Participants: Randomized clinical trial conducted at 22 endocrinology practices in the United States among 203 adults at least 60 ye…
Nature Medicine · 2023 · 194 citations
Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common…
Diabetologia · 2020 · 193 citations
Precision subclassification of type 2 diabetes: a systematic review
Communications Medicine · 2023 · 92 citations
BACKGROUND: Heterogeneity in type 2 diabetes presentation and progression suggests that precision medicine interventions could improve clinical outcomes. We undertook a systematic review to determine whether strategies to subclassify type 2 diabetes were associated with high quality evidence, reproducible results and improved outcomes for patients. METHODS: We searched PubMed and Embase for publications that used 'simple subclassification' approaches using simple categorisation of clinical chara…
Recent grants
NIH · $38.6M · 1996–2028
NIH · $3.7M · 2012
NIH · $4.8M · 2003
Frequent coauthors
- 83 shared
Siri Atma W. Greeley
University of Chicago
- 61 shared
Rochelle N. Naylor
University of Chicago
- 61 shared
Graeme I. Bell
University of Chicago
- 60 shared
Linda A. DiMeglio
Indiana University – Purdue University Indianapolis
- 52 shared
Carmella Evans‐Molina
- 50 shared
Andrea K. Steck
- 49 shared
Norbert Stefan
Deutsches Diabetes-Zentrum e.V.
- 48 shared
Feifei Cheng
Dalian Medical University
Awards & honors
- Past president of the American Diabetes Association (2019)
- Laureate of the Lincoln Academy of Illinois
Similar researchers at University of Chicago
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Louis Philipson
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
